NXSTAGE MEDICAL INC's ticker is NXTM and the CUSIP is 67072V103. A total of 122 filers reported holding NXSTAGE MEDICAL INC in Q1 2015. The put-call ratio across all filers is 0.83 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $1,318,000 | -78.7% | 54,412 | -75.8% | 0.00% | -77.8% |
| Q3 2017 | $6,202,000 | -5.6% | 224,712 | -14.2% | 0.02% | -18.2% |
| Q2 2017 | $6,569,000 | -24.4% | 262,041 | -19.1% | 0.02% | -24.1% |
| Q1 2017 | $8,693,000 | +45.3% | 324,012 | +41.9% | 0.03% | +26.1% |
| Q4 2016 | $5,983,000 | +6.8% | 228,287 | +1.9% | 0.02% | -4.2% |
| Q3 2016 | $5,600,000 | +2.3% | 224,087 | -11.2% | 0.02% | -14.3% |
| Q2 2016 | $5,472,000 | +33.6% | 252,387 | -7.6% | 0.03% | +21.7% |
| Q1 2016 | $4,097,000 | -30.6% | 273,287 | +1.4% | 0.02% | -34.3% |
| Q4 2015 | $5,903,000 | +58.5% | 269,421 | +15.2% | 0.04% | +52.2% |
| Q3 2015 | $3,724,000 | +20.7% | 233,887 | +8.3% | 0.02% | -4.2% |
| Q2 2015 | $3,085,000 | +68.1% | 215,988 | +103.6% | 0.02% | +71.4% |
| Q1 2015 | $1,835,000 | +425.8% | 106,087 | +444.4% | 0.01% | +366.7% |
| Q4 2014 | $349,000 | -30.1% | 19,487 | -44.3% | 0.00% | -57.1% |
| Q2 2013 | $499,000 | – | 34,987 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ORACLE INVESTMENT MANAGEMENT INC | 2,671,936 | $66,772,000 | 10.29% |
| Tamarack Advisers, LP | 2,150,000 | $53,234,000 | 8.37% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 4,099,175 | $102,438,000 | 4.76% |
| DAFNA Capital Management LLC | 238,509 | $5,960,000 | 4.15% |
| KOPP INVESTMENT ADVISORS LLC | 124,997 | $3,124,000 | 3.09% |
| SECTORAL ASSET MANAGEMENT INC | 1,199,869 | $29,985,000 | 2.94% |
| PURA VIDA INVESTMENTS, LLC | 365,000 | $9,121,000 | 2.77% |
| First Light Asset Management, LLC | 250,386 | $6,257,000 | 2.69% |
| Perceptive Advisors | 1,669,703 | $41,726,000 | 2.69% |
| GILDER GAGNON HOWE & CO LLC | 5,890,709 | $147,209,000 | 2.53% |